Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman

Internal Medicine

Volumn 38, Issue 1, 1999, Pages 36-39

  Fujiyama, Soichiro ^a   Mori, Yasukiyo ^a   Matsubara, Hiroaki ^a   Okada, Sonoko ^a   Maruyama, Katsuya ^a   Masaki, Hiroya ^a   Yonemoto, Toshinaga ^a   Nagata, Toshiko ^a   Umeda, Yukihisa ^a   Matsuda, Tadashi ^a   Iwasaka, Toshiji ^a   Inada, Mitsuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Aldosteronoma; Hypertension; Hypokalemia; Pregnancy

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOKALEMIA; LAPAROSCOPIC SURGERY; LUNG CONGESTION; MATERNAL HYPERTENSION; PREGNANCY; PRIMARY HYPERALDOSTERONISM;

EID: 0032936662     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.36     Document Type: Article

References (23)

1. Kaplan NM. Primary aldosteronism. in: Clinical Hypertension, Kaplan NM, Ed. 7th ed., Williams & Wilkins, Baltimore, 1997: 365-382.
2. Webb JC, Bayliss P. Pregnancy complicated by primary aldosteronism. South Med J 90: 243-245, 1997.
3. August P, Lindheimer MD. Hypertension in pregnancy. in: Individualized Therapy of Hypertension, Kaplan NM, Ram CVS, Eds., Marcel Dekker, Inc., New York, 1995: 165-193.
4. Wilson M, Morganti AA, Zervoudakis I, et al. Blood pressure, the reninaldosterone system and sex steroids throughout normal pregnancy. Am J Med 68: 97-104, 1980.
5. Crane MG, Andes JP, Harris JJ, Slate WG. Primary aldosteronism in pregnancy. Obstet Gynecol 23: 200-208, 1964.
6. Aoi W, Doi Y, Tasaki S, Mitsuoka T, Suzuki S, Hashiba K. Primary aldosteronism aggravated during peripartum period. Jpn Heart J 19: 946-953, 1978.
7. Shimizu A, Aoi W, Akahoshi M, et al. Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism. Jpn Heart J 24: 995-1006, 1983.
8. Casey ML, MacDonald PC, Simpson ER. Endocrinological changes of pregnancy. in: Williams Textbook of Endocrinology, Wilson JD, Foster DW, Eds., 8th ed., Saunders, Philadelphia, 1996: 977-991.
9. Biglieri EG, Slaton PE Jr. Pregnancy and primary aldosteronism. J Clin Endocrinol Metab 27: 1628-1632, 1967.
10. Gordon RD, Fishman LM, Liddle GW. Plasma renin activity and aldosterone secretion in a pregnant woman with primary aldosteronism. J Clin Endocrinol Metab 27: 385-388, 1967.
11. Merrill RH, Dombroski RA, MacKenna JM. Primary hyperaldosteronism during pregnancy. Am J Obstet Gynecol 150: 786-787, 1984.
12. Lotgering FK, Derkx FM, Wallenburg HC. Primary hyperaldosteronism in pregnancy. Am J Obstet Gynecol 155: 986-988, 1986.
13. Baron F, Sprauve ME, Huddleston JF, Fisher AJ. Diagnosis and surgical treatment of primary aldosteronism in pregnancy: A case report. Obstet Gynecol 86: 644-645, 1995.
14. Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol 79: 130-137, 1992.
15. Keegan GT, Gravartis F, Roland AS. Pregnancy complicated by Cushing's syndrome. South Med J 69: 1207-1209, 1976.
16. Shibasaki T, Odagiri E, Shizume K, Ling N. Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab 55: 384-386, 1982.
17. Clesham GJ. β Adrenergic agonists and pulmonary oedema in preterm labour. Br Med J 308: 260-262, 1994 (see comments).
18. Braden GL, von Oeyen PT, Germain MJ, Watson DJ, Haag BL. Rotpdrine-and terbutaline-induced hypokalemia in preterm labor: Mechanism and consequences. Kidney Int 51: 1867-1875, 1997.
19. Luchsinger A, Grilli M, Forte P, Morales E, Velasco M. Metclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients. Int J Clin Pharmacol Ther 33: 509-512, 1995.
20. Veglio F, Pinna G, Rabbia F, et al. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension. J Int Med Res 19: 44-49, 1991.
21. Messina M, Biffignandi P, Ghigo E, Jeantet MG, Molinatti GM. Possible contraindication of spironolactone during pregnancy. J Endocrinol Invest 2: 222, 1979 (letter).
22. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96: 451-456, 1994.
23. Aboud E, De Swiet M, Gordon H. Primary aldosteronism in pregnancy -should it be treated surgically? Ir J Med Sci 164: 279-280, 1995.